Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Drug Name | Tagitanlimab |
| Trade Name | |
| Synonyms | KLA167|KL-A167|KL A167 |
| Drug Descriptions |
Tagitanlimab (KL-A167) is a monoclonal antibody targeting CD274 (PD-L1), which potentially inhibits tumor growth (PMID: 40830660, PMID: 36879786). |
| DrugClasses | PD-L1/PD-1 antibody 134 |
| CAS Registry Number | 2417649-97-7 |
| NCIT ID | C163992 |
| Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
|---|---|---|---|
| SKB264 + Tagitanlimab | SKB264 Tagitanlimab | 0 | 0 |
| Tagitanlimab | Tagitanlimab | 0 | 0 |